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DObjective: Many patients with symptomatic hypertrophic cardiomyopathy have minimal left ventricular
outflow tract gradients, and there is uncertainty whether their limitation is due to diastolic dysfunction or labile
outflow tract obstruction. The purpose of this study was to characterize the clinical presentation and outcome of
septal myectomy in patients with hypertrophic cardiomyopathy and latent obstruction.
Methods:Among 749 patients who underwent septal myectomy, 249 had latent obstruction with minimal (0–30
mm Hg) resting gradients preoperatively. All were symptomatic and had more severe left ventricular outflow
tract obstruction provoked by Valsalva maneuver or amyl nitrite inhalation during Doppler echocardiography
or by stimulation with isoproterenol during catheterization. Clinical characteristics, survival, and functional
outcome of these patients were compared with those of 500 patients with more severe resting left ventricular
outflow tract obstruction who underwent myectomy during the same period.
Results:Compared with those with severe obstruction, more patients with latent obstruction were male (63% vs
52%, P<.003), but ages were similar (53  14 years vs 52 15 years). Preoperative symptoms and functional
limitation were similar in the 2 groups with 86% and 85%, respectively, having New York Heart Association
class III or IV disability. Among patients with latent obstruction, mixed venous oxygen saturation was 61.6%
19.0% of predicted compared with 56.8% 17.3% for those with severe resting obstruction (P<.008). Septal
thickness was less in patients with latent obstruction (20 9 mm vs 22 15 mm, P<.001). Early mortality was
1% in each group, and survival at 5 and 10 years was 93% and 87%, respectively, for patients with latent ob-
struction compared with 93% and 74%, respectively, for patients with severe resting obstruction preoperatively
(P ¼ .34). Self-reported late functional status was similar; 3 to 5 years postoperatively, 81% of patients with
latent obstruction preoperatively were in New York Heart Association class I or II compared with 77% of
patients with severe resting obstruction.
Conclusions: Patients with obstructive hypertrophic cardiomyopathy who have low resting gradients and latent
obstruction may have limiting symptoms comparable to those of patients with more severe resting gradients.
Septal myectomy should be offered to these patients because survival and symptom relief are excellent, suggest-
ing that dynamic obstruction is the major hemodynamic problem rather than diastolic dysfunction. (J Thorac
Cardiovasc Surg 2012;143:303-9)Standard indications for operation in patients with hypertro-
phic cardiomyopathy (HCM) include symptoms refractory
to medical treatment and severe left ventricular outflow
tract (LVOT) obstruction with a resting gradient of more
than 30 mm Hg. Indeed, many experts believe that septal
myectomy is the gold standard for treatment of symptom-
atic patients with obstructive HCM.1,2 Previously theree Divisions of Cardiovascular Surgery and Cardiovascular Diseases, Mayo
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The Journal of Thoracic and Cawas debate regarding the clinical importance of outflow
tract obstruction in patients with HCM, and population-
based studies reported significant obstruction in only 20%
to 44% of patients with HCM.3 Recent reports from Maron
and associates4 and Elliott and associates5 suggest that
outflow tract obstruction is a significant risk factor for late
death in patients with HCM, and relief of gradients by
surgical myectomy may improve survival.6
Symptoms, especially exertional dyspnea and fatigue,
can be produced by severe diastolic dysfunction in patients
with HCM without LVOT obstruction.7 Thus, there may be
uncertainty in individual patients of the importance of min-
imal resting gradients in the pathophysiology of limiting
symptoms. It is now recognized that in a sizable proportion,
patients with minimal LVOT gradients at rest will have
larger gradients provocable after exercise, Valsalva maneu-
ver, administration of amyl nitrite, or isoproterenolrdiovascular Surgery c Volume 143, Number 2 303
Abbreviations and Acronyms
HCM ¼ hypertrophic cardiomyopathy
HR ¼ hazard ratio
LVOT ¼ left ventricular outflow tract
NYHA ¼ New York Heart Association
PVC ¼ premature ventricular contraction
SAM ¼ systolic anterior motion
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Dinfusion.8,9 The dilemma, then, is whether septal reduction
for relief of the inducible LVOT obstruction will lead to
clinical improvement. To address this question, we have
compared outcome (survival and functional status) of
patients with HCM and latent LVOT obstruction who
underwent septal myectomy with that of patients who had
myectomy for relief of severe resting LVOT obstruction.
MATERIALS AND METHODS
Patient Selection
The study was reviewed and approved by the Mayo Clinic Institutional
Review Board. The need for individual patient consent was waived because
relevant identifiers were not included in the data set, and we excluded pa-
tients who declined involvement in clinical research in accordance with
Minnesota statutes. From January 4, 1993, to December 31, 2007, 1029 pa-
tients with HCM underwent septal myectomy. Cardiologists in our HCM
Clinic recorded preoperative evaluations, including assessment of resting
LVOT gradients in 749 of these patients who form the study cohort. The
remaining 280 patients who underwent operation had preprocedural eval-
uation by other referring cardiologists and were excluded because of
lack of standardized documentation of resting or provocable LVOT gradi-
ents. Also, the series does not include patients with the primary diagnosis of
valvular aortic stenosis who underwent aortic valve replacement and
concomitant septal myectomy for treatment of LVOT obstruction due to
secondary septal hypertrophy.10
Latent obstruction was defined as LVOT pressure gradient 30 mmHg or
less at rest that increased to more than 50 mm Hg with provocation.2,9
Latent obstruction was often suspected from findings at initial screening
evaluation. When there was no resting gradient on prior imaging studies,
maneuvers such as Valsalva and stand to squat often provoked a typical
systolic murmur signaling dynamic outflow tract obstruction.
All patients had echocardiographic or invasive hemodynamic data
documentation of resting and provocable gradients. Medications were
not withheld, and echocardiographic studies were performed at baseline
according to the recommendations of the American Society of Echocardi-
ography. LVOT gradients were measured with continuous-wave Doppler
of the outflow tract from an apical window and calculated using the
modified Bernoulli equation (ie, gradient ¼ 4v2, where v ¼ peak LVOT
velocity). Most patients underwent provocation with amyl nitrite or
Valsalva maneuver; however, in a small number of patients, gradients
were measured after exercise, isoproterenol, dobutamine, or a premature
ventricular contraction (PVC). During provocative maneuvers, both
2-dimensional and Doppler data were used to confirm the presence of
true outflow tract obstruction. Images were assessed for the presence of
systolic anterior motion (SAM) of the mitral valve and absence of com-
plete systolic cavity obliteration, and for hemodynamic measurement,
the Doppler signal was required to have the typical late-peaking character-
istics of a dynamic obstruction.
Invasive catheterization studies were performed with conscious seda-
tion, and cardiac medications were continued the day of the procedure.304 The Journal of Thoracic and Cardiovascular SurgFemoral venous access was used to gain access to the right heart, and
left heart pressure measurements were performed via transseptal puncture
using 7F or 8F catheters; the transseptal approach was used to measure left
ventricular inflow pressures, which avoids catheter entrapment. A typical
spike and dome pattern was required to be present on the aortic pressure
trace to ensure dynamic obstruction was present. Simultaneous
2-dimensional echocardiography was always performed during catheteri-
zation to ensure that there was associated SAM of the mitral valve during
provocation.
Left ventricular pressure measurements were taken in conjunction with
cineangiography to avoid catheter entrapment and associated erroneous
pressure readings. Central aortic pressure was obtained from retrograde
femoral artery access with 6F or 7F catheters, and LVOT gradient at cardiac
catheterization was calculated as peak left ventricular systolic pressure
minus the peak central aortic pressure before and after isoproterenol
stimulation.11-13Operative Management
Operations were performed using standard median sternotomy, normo-
thermic cardiopulmonary bypass with single venous cannula, and ante-
grade cold blood cardioplegia for myocardial protection. Through a low
oblique aortotomy, myectomy was performed with a standard number 10
scalpel blade with incision in the septum beginning just to the right of
the nadir of the right aortic sinus. Initial incision in the septum was
made upward and then leftward over to the anterior leaflet of the mitral
valve. Scissors were used to complete excision of this initial portion of
myocardium, and the area of septal excision was then deepened and length-
ened toward the apex of the heart being certain to excise hypertrophied
septum beyond endocardial scar. After trabeculations were excised, the
myectomy site was further enlarged with the use of pituitary rongeurs.14
No patient had mitral valve replacement as primary treatment of LVOTob-
struction. In most patients, associatedmitral valve regurgitation was related
to SAM and improved bymyectomy alone. For patients with associated de-
generative mitral valve disease, the valve was replaced in 15 patients and
repaired in 95 patients.15
To confirm complete relief of the LVOTobstruction, we used intraoper-
ative echocardiography16 and routinely measured simultaneous aortic and
left ventricular pressure by direct needle puncture before and after myec-
tomy.17 If the patient had latent obstruction or the resting LVOT gradient
was diminished by effects of anesthesia, provocation was by induction of
PVC or isoproterenol administration. PVC was induced by mechanical
stimulation of the right ventricle. Isoproterenol challenge was carried out
by titrated infusion via a pulmonary catheter to achieve a heart rate greater
than 120 beats/min or an LVOT gradient greater than 50mmHg. Aortic and
left ventricular pressures were recorded during the same maneuvers after
myectomy.Follow-up and Analysis
Statistical analyses were performed using SAS software (version 9.1;
SAS Institute Inc, Cary, NC). Descriptive statistics for categoric variables
are reported as frequency and percentage, and continuous variables are
given as mean (standard deviation). Late survival was determined for all
patients from medical records, Accurint (www.accurint.com), and surveys.
The Kaplan–Meier method was used to estimate late survival, and
estimates extend to 12 years. Observed mortality was compared using
a log-rank test to expected survival of an age- and sex-matched US general
population for the entire follow-up period. Functional status was deter-
mined by responses to questionnaires that are sent to postoperative patients
1, 3, 5, 7, 10, and 15 years after operation. This was supplemented by
information from medical records when new information was available.
In the analysis of functional status, we used the most current follow-up
information. For patients who died during follow-up, we used available
information on cardiac status 6 months before death.ery c February 2012
TABLE 1. Concomitant cardiac procedures performed in 277 patients
who underwent transaortic septal myectomy
Procedure No. of patients
Mitral valve repair 95
CABG 67
Maze procedure 38
AVR 32
ASD or PFO repair 26
Aortic valve repair 23
Excision of fibroelastoma or other valve tumor 17
MVR 15
Tricuspid valve repair 7
Unbridging of coronary artery 6
Replacement of ascending aorta 5
Pericardiectomy 3
Miscellaneous 6
Miscellaneousprocedures include repair of ascending aortic aneurysm, left atrial throm-
bectomy, repair of left ventricular aneurysm, right ventricular outflow reconstruction,
and carotid endarterectomy. Note that patients may have had more than 1 additional
procedure. CABG, Coronary artery bypass graft; AVR, aortic valve replacement; ASD,
atrial septal defect; PFO, patent foramen ovale;MVR, mitral valve replacement.
TABLE 2. Preoperative patient characteristics stratified by
preoperative left ventricular outflow tract gradient
Covariate
30 mm Hg
(n ¼ 249)
>30 mm Hg
(n ¼ 500)
P
value
Male (no.) 156 (62.7%) 260 (52%) .006
Age (y, mean  SD) 53.1  14.4 51.9  15.1 .295
Body mass index (kg/m2,
mean  SD)
30.2  5.5 30.1  5.8 .737
Body surface area
(m2, mean SD)
2.0  0.2 2.0  0.3 .792
NYHA class III or IV (no.) 215 (86.3%) 427 (85.4%) .728
Dyspnea (no.) 178 (72.9%) 371 (74.9%) .205
Angina (no.) 48 (21.3%) 131 (29.1%) .124
Presyncope (no.) 163 (69.3%) 290 (69.1%) .159
Syncope (no.) 54 (22.4%) 90 (18.9%) .373
Preoperative AF 45 (18.1%) 82 (16.4%) .321
Medications
ß-blocker 188 (75.5%) 356 (71.2%) .214
Caþþ-blocker 111 (44.6%) 193 (38.6%) .117
Disopyramide 29 (11.6%) 48 (59.6%) .385
Amiodarone 18 (7.3%) 25 (5%) .217
Previous cardiac surgery (no.) 33 (13.3%) 58 (11.6%) .514
Permanent pacemaker
or ICD (no.)
54 (21.7%) 77 (15.4%) .033
SD, Standard deviation; NYHA, New York Heart Association; ICD, implantable
cardioverter defibrillator; AF, atrial fibrillation.
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DRESULTS
Among all 749 patients, the mean age was 52.3  14.9
years, and 56% were male. Concomitant procedures were
performed in 277 patients and are listed in Table 1. The
most common associated operations were mitral valve re-
pair and coronary artery bypass grafting, performed in
12.7% and 8.9% of patients, respectively. Transaortic sep-
tal myectomy was an isolated procedure in 65% of patients
with latent LVOT obstruction and a similar percentage of
patients with severe resting gradients. Overall, 85.7% of pa-
tients had severe limitation (New York Heart Association
[NYHA] class III or IV) preoperatively, and the most com-
mon symptom was exertional dyspnea, present in 73.2% of
patients.
In Table 2, preoperative variables are stratified for pa-
tients with (n¼ 249) and without (n¼ 500) latent LVOTob-
struction. General demographic features of the patients
were similar except for a higher proportion of male patients
in the group with latent obstruction (62.7% vs 52%,
P¼ .006). Presenting symptoms, extent of preoperative dis-
ability, and medication use were similar in the 2 groups;
a slightly greater proportion of patients with latent obstruc-
tion had preoperative pacemaker/defibrillators in place at
the time of operation (21.7% vs 15.4%, P ¼ .033).
Average resting LVOT gradient was 14.0 9.9 mmHg in
patients with latent obstruction compared with 80.9  33.7
mm Hg for patients with severe resting obstruction
preoperatively. As seen in Table 3, patients with latent
LVOT obstruction had slightly better exercise capacity pre-
operatively as judged by mixed venous oxygen saturation
compared with patients with severe obstruction. Also, pa-
tients with latent LVOT obstruction had less severe mitral
valve regurgitation (37.2%>grade 2 vs 65.0%, P<.001).The Journal of Thoracic and CaLeft ventricular systolic function was hyperdynamic in
both groups, although preoperative ejection fraction was
somewhat lower in the group with latent obstruction.
Pertinent outcome measures are presented in Table 4.
Durations of cardiopulmonary bypass and aortic cross-
clamping were shorter in the group with latent LVOT ob-
struction compared with patients with more severe resting
obstruction. Mortality, need for permanent pacing or im-
plantable cardioverter defibrillator, and median length of
hospitalization were similar in the 2 groups.
For all patients, 5-year survival was 92.9% and 10-year
survival was 77%. As seen in Figure 1, there was no signif-
icant difference in late survival after septal myectomy of pa-
tients with latent LVOTobstruction versus those with severe
resting obstruction preoperatively. This was true for all pa-
tients and those having isolated septal myectomy (Figure 2).
Survival of all patients who had septal myectomy was re-
duced compared with that of an age- and gender-matched
population (10-year survival 77.9% vs 85.3%, P<.001).
This difference was due largely to reduced late postopera-
tive survival in patients with high resting LVOTobstruction
preoperatively (P<.001, Figure 3). Late survival of patients
who had septal myectomy for latent LVOT obstruction was
almost identical to expected survival (Figure 4).
Significant predictors of overall (early and late) mortality
for the entire cohort of patients undergoing myectomy
(n ¼ 749) were older age (hazard ratio [HR], 1.04;
P < .001), preoperative atrial fibrillation (HR, 1.84;
P ¼ .011), and need for a concomitant cardiac procedurerdiovascular Surgery c Volume 143, Number 2 305
TABLE 3. Echocardiographic and hemodynamic characteristics of patients stratified by preoperative left ventricular outflow gradient
Covariate 30 mm Hg (n ¼ 249) >30 mm Hg (n ¼ 500) P value
Body mass index (kg/m2, mean) 30.2  5.5 30.1  5.8 0.737
Body surface area (m2, mean  SD) 2.0  0.2 2.0  0.3 0.792
Mixed venous oxygen saturation (% predicted, mean  SD) 61.6  19.0 56.8  17.3 0.008
LVOT gradient (mm Hg, mean  SD) 14.0  9.9 80.9  33.7 <0.001
Septal thickness (mm, mean  SD) 20.5  9.0 22.2  15.5 <0.001
MR>grade 2 (no.) 93 (37.3%) 325 (65.0%) <0.001
Ejection fraction (%, mean  SD) 70.6  7.9 72.1  6.6 0.032
SD, Standard deviation; LVOT, left ventricular outflow tract; MR, mitral regurgitation.
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D(HR, 1.81; P¼ .006). In a multivariate Cox regression anal-
ysis, only older age was a significant predictor of mortality
(HR, 1.04; P < .001), and when latent obstruction was
forced into the model, the resulting HRwas 0.76 (P¼ .266).
Preoperatively, 86% of patients were in NYHA class III
or IV, and there was no difference in degree of functional
impairment comparing patients with latent obstruction
with those with more severe resting obstruction. As seen
in Figure 5, the extent of functional improvement was sim-
ilar for the 2 patient groups 5 to 7 years after myectomy, and
79% of patients in each group were in NYHA class I or II.
Beyond 7 years postoperatively, follow-up information was
available in 114 patients; 52.2% of patients with latent ob-
struction and 61.2% of patients with severe resting obstruc-
tion preoperatively were in NYHA class I or II.DISCUSSION
In patients with HCM, the importance of latent obstruc-
tion (defined as a left ventricular outflow pressure gradientTABLE 4. Intraoperative and early postoperative outcomes of
patients stratified by preoperative left ventricular outflow gradient
Covariate
30 mm Hg
(n ¼ 249)
>30 mm Hg
(n ¼ 500)
P
value
CPB time (min, mean  SD)
All patients 50.8  28.7 55.2  32.5 .058
Isolated myectomy 39.0  19.1 43.3  20.3 .011
Crossclamp time (min, mean  SD)
All patients 35.6  22.0 40.5  23.9 .002
Isolated myectomy 27.1  14.9 32.3  16.6 <.001
Early mortality (no.)
All patients 2 (0.8%) 5 (1.0%) .792
Isolated myectomy 0 (0%) 2 (0.6%) .317
New pacemaker for bradycardia
All patients 6 (2.4%) 21 (3.2%) .216
Isolated myectomy 3 (1.6%) 15 (4.6%) .128
ICD for prevention of SCD (no.)
All patients 15 (6.0%) 36 (7.2%) .547
Isolated myectomy 7 (4.3%) 25 (7.7%) .157
Length of hospitalization (median)
All patients 6 6 .932
Isolated myectomy 6 6 .719
SD, Standard deviation; CPB, cardiopulmonary bypass; ICD, internal cardioverter
defibrillator; SCD, sudden cardiac death.
306 The Journal of Thoracic and Cardiovascular Surg<30 mm Hg at rest that increases to50 mm Hg with prov-
ocation) has been recognized only recently. Indeed, most
studies evaluating survival and symptom progression of
obstructive HCM have stratified patients by the presence
or absence of resting gradients of 30 mm Hg or
more.4,5,18 However, it is well known that LVOT gradients
in HCM may be highly variable,12 and patients with latent
obstruction constitute a sizable subgroup. Resting outflow
tract gradients of 50 mm Hg or more were documented by
Maron and colleagues8 in 37% of 320 patients with
HCM, and, more important, exercise-induced gradients
(mean, 80  43 mm Hg) were found in an additional 106
patients; thus, as many as 70% of patients with HCM
who come to clinical evaluation will have significant out-
flow tract obstruction.
Cardiologists in our HCMClinic have recognized the im-
portance of latent LVOT obstruction and reported that
NYHA class III or IV symptoms are present in approxi-
mately 20% of patients at initial evaluation; in patients
with only mild or moderate limitation, symptoms progress
in 18% over a median follow-up of 7.4 years.9 Thus, a con-
siderable number of patients with latent LVOT obstruction
have serious functional impairment despite medical treat-
ment and may be candidates for septal reduction therapy.
Indeed, patients with HCM with latent obstruction consti-
tute 33% of our recent surgical experience with transaortic
septal myectomy.
Relief of LVOT obstruction by transaortic septal myec-
tomy improves symptoms in more than 85% of patients
with severe resting obstruction.19 However, diastolic dys-
function is a major pathophysiologic mechanism in HCM;
elevation of the left ventricular end-diastolic pressure and
increase in left atrial and pulmonary venous pressures
may lead to symptoms of effort dyspnea and limited aerobic
capacity. As diastolic dysfunction progresses, left ventricu-
lar filling becomes more dependent on atrial contraction,
and atrial arrhythmias, especially atrial fibrillation, may
precipitate acute and profound decrease in cardiac output
and worsening of symptoms. In symptomatic patients
with minimal resting LVOT gradients, there is often uncer-
tainty regarding the hemodynamic importance of obstruc-
tion and the role of septal reduction therapy. This
dilemma was highlighted by 1 patient in this series withery c February 2012
FIGURE 1. Overall survival of all patients after transaortic septal myec-
tomy. Survival was similar for patients with latent obstruction (30 mm
Hg) preoperatively compared with those with more severe obstruction
(>30 mm Hg).
FIGURE 3. Overall survival of patients after transaortic septal myectomy
who had high resting gradients preoperatively (>30 mm Hg). Survival of
these patients was reduced in comparison with age- and gender-matched
population (P<.001).
Schaff et al Acquired Cardiovascular Disease
A
C
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tomy at another institution. The operation was aborted after
general anesthesia and prepping and draping for sternotomy
because the intraoperative transesophageal echocardiogram
showed no obstruction and no SAM of the mitral valve. The
patient remained symptomatic with exertional dyspnea until
completion of extended septal myectomy at the HCM
Clinic.
The present study documents that patients with latent ob-
struction referred for operation have similar presenting
symptoms and functional limitation as patients with more
severe resting outflow gradients. The severity of mitral re-
gurgitation at rest was significantly lower in patients with
latent obstruction compared with those with high resting
gradients, and this is consistent with SAM as a causativeFIGURE 2. Overall survival of patients after isolated transaortic septal
myectomy. Survival was similar for patients with latent obstruction
(30 mm Hg) preoperatively compared with those with more severe ob-
struction (>30 mm Hg).
The Journal of Thoracic and Camechanism of both LVOT obstruction and mitral regurgita-
tion in most patients. The findings that patients with latent
obstruction had less septal hypertrophy and better objective
exercise performance suggest that latent obstruction may
represent a transition phase from nonobstructive to obstruc-
tive HCM. It might be hypothesized that patients with labile
LVOT obstruction would be more responsive to medical
treatment than patients with severe resting outflow tract gra-
dients. Analysis of this surgical cohort cannot address this,
but patients with latent obstruction who underwent septal
myectomy had similar medication use as patients with
severe resting obstruction.
Of note, our investigation demonstrates that patients with
HCM and latent obstruction preoperatively have excellent
survival and functional improvement after transaortic
myectomy. Operative risk was low for patients with latent
obstruction, and subsequent survival was similar to that of
patients with severe resting obstruction. Indeed, 10-yearFIGURE 4. Overall survival of patients after transaortic septal myectomy
who had latent obstruction preoperatively (30 mm Hg). Survival of these
patients was similar to an age- and gender-matched population.
rdiovascular Surgery c Volume 143, Number 2 307
FIGURE 5. Percentages of patients reporting NYHA class I or II status
preoperatively and during follow-up after septal myectomy. There is no sig-
nificant difference in degree of improvement postoperatively comparing
patients with latent obstruction (30 mm Hg) preoperatively with those
with more severe obstruction (>30 mm Hg).
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including patients with concomitant procedures, was iden-
tical to an age-matched group. This finding, along with
the comparable improvement in functional status late after
operation, suggests that the major contributor to symptoms
in patients with latent obstruction is the dynamic outflow
gradient rather than severe diastolic dysfunction.
Although septal myectomy is usually performed for relief
of symptoms, some consideration should be given to possi-
ble improvement in survival after operation. Severe resting
LVOT obstruction seems to increase mortality in patients
with HCM.4,5 Maron and colleagues4 reported that risk of
death from HCM was increased 2-fold in patients with out-
flow tract obstruction (a basal gradient of at least 30 mm
Hg) compared with patients without obstruction, and risk
of progression to NYHA class III or IVor death from heart
failure or stroke was increased 4-fold.4 Ommen and col-
leagues6 reported that late survival of patients with HCM
who had septal myectomywas similar to survival of patients
with HCM without obstruction, and patients with myec-
tomy had improved HCM-related mortality and freedom
from sudden cardiac death compared with unoperated pa-
tients with HCM with obstruction. More recently, Sorajja
and colleagues20 found that even in the absence of severe
cardiac symptoms, the magnitude of the resting LVOT
gradient is directly and independently associated with in-
creasing risk of adverse clinical outcome.
The impact of outflow gradients on late survival is less
well documented in patients with latent LVOT obstruction.
In the study by Vaglio and colleagues,9 patients with HCM
with latent obstruction and severe symptoms had a trend to-
ward reduced late survival (P ¼ .06), and better outcome
was observed in 82 of these patients who had septal reduc-
tion by alcohol septal ablation or myectomy. The favorable
impact of septal reduction therapy on mortality is supported308 The Journal of Thoracic and Cardiovascular Surgby the finding in the present study that late survival of pa-
tients with latent obstruction who have myectomy is identi-
cal to expected survival of an age and gender-matched
population.
Alcohol septal ablation (infarction) is an alternative treat-
ment for patients with drug-refractory symptoms caused by
obstructive HCM, and this option is discussed with patients
who are candidates for septal reduction. In our experience,
alcohol septal ablation improves symptoms in 76% of pa-
tients at 4 years, but the in-hospital complication rate is
higher with alcohol ablation than with myectomy, and the
question of enhanced propensity for ventricular arrhythmia
remains unanswered.21 Further, in those patients aged 65
years, symptom relief is better after myectomy, and, for
these reasons, we believe surgical myectomy is the pre-
ferred technique for septal reduction in patients who are
in good general health and have no contraindications for
surgery.CONCLUSIONS
Patients with obstructive HCMwho have low resting gra-
dients and latent obstruction may have limiting symptoms,
similar in character and severity to those of patients with
more severe resting gradients. Septal myectomy should be
offered to these patients because survival and symptom
relief are excellent, suggesting that dynamic obstruction is
the major hemodynamic problem rather than diastolic
dysfunction.References
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Dr Ralph Damiano (St. Louis, Mo). Dr Schaff, I congratulate
you and your coauthors on an important contribution. This is
a landmark report that will have a significant impact on the clinical
management of patients with symptomatic HCM.
The study stresses the importance of a team approach in the ma-
nagement of HCM and a careful preoperative echocardiographicThe Journal of Thoracic and Caexamination for provocable gradients in these patients. I have
several questions for you regarding this excellent contribution.
The first question is, what was the range of provocable gradi-
ents, particularly in the latent group? Were patients with higher
provocable gradients more likely to have late symptomatic
relief?
Dr Schaff. We don’t have information on the extent of the
provocable gradients other than being able to say it was more
than 50 mm Hg, and the reason is that once the patient achieved
that gradient with a Valsalva maneuver, cardiologists did not go
further with provocation with Isuprel or exercise that may have in-
creased with gradient further. The provoked gradient, then, is not
the maximum provoked gradient.
Dr Damiano. Did you find any preoperative or intraoperative
correlates with poor late functional outcome? Particularly when
you went back and looked at the patients who had recurrent heart
failure, were they the patients who had preoperative echocardio-
graphic criteria for diastolic dysfunction?
Dr Schaff.We don’t have any information on diastolic dysfunc-
tion, but it makes sense that patients with a larger left ventricular
mass have more diastolic dysfunction and might be more likely to
have late heart failure.
Dr Damiano. I was intrigued with the large number of patients
who underwent concomitant mitral valve surgery.Would you com-
ment on your techniques of mitral valve repair in these patients?
Did the presence of preoperative mitral regurgitation or residual
postoperative mitral regurgitation correlate with functional
improvement?
Dr Schaff. No. The mitral regurgitation for most patients with
dynamic outflow tract obstruction will be improved with myec-
tomy alone. Of approximately 10% of patients who had some-
thing done to the mitral valve, most had intrinsic degenerative
mitral valve disease as an associated problem. There were
a few who had injury to the mitral valve during myectomy. Our
approach is to first perform the myectomy, discontinue cardiopul-
monary bypass, and then reassess the valve once the obstruction is
relieved to see whether there is residual regurgitation. If mitral re-
gurgitation persists, we would resume extracorporeal circulation
and repair the valve. I think it is important to assess the valve
once the gradient is relieved before making a decision for valve
repair.
Dr Damiano. Thank you. Congratulations.rdiovascular Surgery c Volume 143, Number 2 309
